Chapter 15. Glucose Abnormalities and Cardiovascular Disease: “Dysglycemia” as an Emerging Cardiovascular Risk Factor

  1. Salim Yusuf1,
  2. John A Cairns2,
  3. A John Camm3,
  4. Ernest L Fallen4 and
  5. Bernard J Gersh5
  1. Sarah E Capes and
  2. Hertzel C Gerstein

Published Online: 4 OCT 2007

DOI: 10.1002/9780470986882.ch15

Evidence-based Cardiology, Second Edition

Evidence-based Cardiology, Second Edition

How to Cite

Capes, S. E. and Gerstein, H. C. (2002) Glucose Abnormalities and Cardiovascular Disease: “Dysglycemia” as an Emerging Cardiovascular Risk Factor, in Evidence-based Cardiology, Second Edition (eds S. Yusuf, J. A. Cairns, A. J. Camm, E. L. Fallen and B. J. Gersh), BMJ Books, London, UK. doi: 10.1002/9780470986882.ch15

Editor Information

  1. 1

    Heart and Stroke Foundation of Ontario Research Chair, Senior Scientist of the Canadian Institute of Health Research, Director of Cardiology and Professor of Medicine, McMaster, University, Hamilton Health Sciences, Hamilton, Canada

  2. 2

    Dean, Faculty of Medicine, University of British Columbia, Vancouver, Canada

  3. 3

    Professor of Clinical Cardiology and Chief, Department of Cardiological Sciences, St George's Hospital Medical School, London, UK

  4. 4

    Professor Emeritus, McMaster University, Faculty of Health Sciences, Hamilton, Canada

  5. 5

    Consultant in Cardiovascular Diseases and Internal Medicine, Mayo Clinic; Professor of Medicine, Mayo Medical School, Rochester, Minnesota, USA

Publication History

  1. Published Online: 4 OCT 2007
  2. Published Print: 20 NOV 2002

ISBN Information

Print ISBN: 9780727916990

Online ISBN: 9780470986882



  • dysglycemia;
  • epidemiology;
  • impaired glucose tolerance;
  • etiologic classification;
  • glucose levels


This chapter contains sections titled:

  • Definition and epidemiology of diabetes and impaired glucose tolerance

  • Prevalence estimates

  • Relationship between the glucose level and retinopathy, nephropathy, and peripheral neuropathy

  • Relationship between the glucose level and the risk of cardiovascular disease

  • Mechanisms relating hyperglycemia to cardiovascular disease

  • Is glucose a modifiable cardiovascular disease risk factor

  • Conclusion